Lionco Pharmaceutical GroupLtd's high P/S ratio is alarming due to its falling revenue. Unless there's a significant improvement in medium-term conditions, the current share price may not be considered fair value. The company's declining revenue and high P/S ratio could negatively impact the future share price.